Tim Obara | SVP, Corporate Development
Jurata Thin Film, Inc.

Tim Obara, SVP, Corporate Development, Jurata Thin Film, Inc.

 Tim Obara is a seasoned biopharmaceutical executive with over 30 years of global experience spanning vaccines, oncology, and cell and gene therapy. He has held leadership roles across commercial, manufacturing, business development, and R&D strategy at companies including Merck, GSK, AstraZeneca, Amicus Therapeutics, and Genenta Science. Tim also played a key operational role at the University of Pennsylvania’s Gene Therapy Program, where he led the Vivarium team and secured AAALAC accreditation for a new facility. His career reflects a consistent focus on advancing transformative therapies, scaling innovation, and driving value through strategic partnerships and capital markets in both the U.S. and Europe.

Appearances:



Day 1 - Tuesday 14th October @ 16:00

Thermostability: Formulations That Bridge All Modalities

Session led by: Jurata Thin Film, Inc.
last published: 16/Jul/25 14:15 GMT

back to speakers

Get involved at World Vaccine Congress Europe 2025

 

 

TO SPONSOR


Christian Larsmon

Christian.Larsmon@terrapinn.com

 

Otto Squire
Otto.Squire@terrapinn.com

 

TO SPEAK


Isla Sutherland

Isla.Sutherland@terrapinn.com

 

MARKETING & PRESS


Jasper Cameron

Jasper.Cameron@terrapinn.com

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.